This inventor holds 0 USPTO granted patents, plus 11 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Jo Klaveness: Innovator in Pharmaceutical Science
Introduction
Jo Klaveness is a notable inventor based in Norway, recognized for his contributions to pharmaceutical science. He has focused on developing innovative methods and formulations that enhance the efficacy of pharmaceutical products. Although he currently holds no patents, his work has significant implications in the field of drug development.
Latest Patents
Jo Klaveness has been involved in the development of several innovative concepts. His latest patents include "Powders And Tablets Comprising Omega-3 Fatty Acid Derivatives And Methods For Their Production." This invention relates to methods of using surface-active compounds in the preparation process for powders comprising beta-cyclodextrin and omega-3 fatty acids and derivatives thereof. Another significant patent is "Salts Of Photosensitizing Agents," which pertains to pharmaceutically acceptable salts of amphiphilic photosensitizing agents that exhibit increased water solubility. These salts are particularly suitable for use in the preparation of parenteral pharmaceutical preparations.
Career Highlights
Throughout his career, Jo Klaveness has worked with various organizations that focus on drug discovery and biotechnology. Notable companies he has been associated with include Drug Discovery Laboratory AS and PCI Biotech AS. His experience in these companies has allowed him to contribute to significant advancements in pharmaceutical formulations.
Collaborations
Jo Klaveness has collaborated with esteemed professionals in his field, including Cees Vermeer and Leon J. Schurgers. These collaborations have fostered innovation and have been instrumental in the development of his research.
Conclusion
Jo Klaveness is a dedicated inventor whose work in pharmaceutical science continues to influence the industry. His innovative approaches to drug formulation and development highlight the importance of research in creating effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile